🇺🇸 FDA
Patent

US 8236829

Bicyclic derivatives as modulators of voltage gated ION channels

granted A61PA61P1/00A61P13/02

Quick answer

US patent 8236829 (Bicyclic derivatives as modulators of voltage gated ION channels) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Aug 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P1/00, A61P13/02, A61P19/02, A61P21/00